Eton Pharmaceuticals Inc’s filing revealed that its 10% Owner Opaleye Management Inc. acquired Company’s shares for reported $79814.0 on Oct 23 ’24. In the deal valued at $7.98 per share,10,000 shares were bought. As a result of this transaction, Opaleye Management Inc. now holds 2,770,000 shares worth roughly $48.86 million.
Then, Opaleye Management Inc. bought 33,970 shares, generating $238,782 in total proceeds. Upon buying the shares at $7.03, the 10% Owner now owns 2,760,000 shares.
Before that, Opaleye Management Inc. bought 16,852 shares. Eton Pharmaceuticals Inc shares valued at $114,105 were divested by the 10% Owner at a price of $6.77 per share. As a result of the transaction, Opaleye Management Inc. now holds 2,720,000 shares, worth roughly $47.98 million.
H.C. Wainwright reiterated its Eton Pharmaceuticals Inc [ETON] rating to a Buy in a research note published on January 23, 2025; the price target was $33. A number of analysts have revised their coverage, including B. Riley Securities’s analysts, who began to cover the stock in early January with a ‘”a Buy”‘ rating. H.C. Wainwright also remained covering ETON and reiterated its “Buy” recommendation on January 06, 2025.
Price Performance Review of ETON
On Tuesday, Eton Pharmaceuticals Inc [NASDAQ:ETON] saw its stock jump 7.17% to $17.64. Over the last five days, the stock has gained 15.52%. Eton Pharmaceuticals Inc shares have risen nearly 32.43% since the year began. Nevertheless, the stocks have risen 297.30% over the past one year. While a 52-week high of $17.35 was reached on 01/28/25, a 52-week low of $3.03 was recorded on 01/08/25. SMA at 50 days reached $12.84, while 200 days put it at $6.78.
Levels Of Support And Resistance For ETON Stock
The 24-hour chart illustrates a support level at 16.73, which if violated will result in even more drops to 15.83. On the upside, there is a resistance level at 18.15. A further resistance level may holdings at 18.67. The Relative Strength Index (RSI) on the 14-day chart is 72.85, which indicates overbought technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 2.30, which suggests price will go up in the next trading period. Percent R suggests that price movement has been bullish at 1.95%. Stochastics %K at 92.11% indicates the stock is a selling.
How much short interest is there in Eton Pharmaceuticals Inc?
A steep rise in short interest was recorded in Eton Pharmaceuticals Inc stocks on 2024-10-31, growing by 65600.0 shares to a total of 0.19 million shares. Yahoo Finance data shows the prior-month short interest on 2024-09-30 was 0.13 million shares. There was a rise of 34.18%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on May 06, 2024 when Craig Hallum began covering the stock and recommended ‘”a Buy”‘ rating along with a $8 price target.
